![John W. Martin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John W. Martin
Corporate Officer/Principal bij The European Commission
Actieve functies van John W. Martin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The European Commission | Corporate Officer/Principal | 25-11-2010 | - |
University College London | Corporate Officer/Principal | - | - |
Loopbaan van John W. Martin
Eerdere bekende functies van John W. Martin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
United Kingdom Ministry of Home Affairs | Corporate Officer/Principal | 01-01-2006 | 01-01-2006 |
The European Society of Cardiology | Corporate Officer/Principal | 01-01-2002 | 01-01-2002 |
Wellcome Research Laboratories | Hoofd Techniek/Wetenschap/O&O | 01-01-1996 | 01-01-1996 |
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 11-09-2009 | - |
Oprichter | 11-09-2009 | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Verenigde Staten | 2 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sectoraal
Government | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Wellcome Research Laboratories | |
The European Society of Cardiology | |
United Kingdom Ministry of Home Affairs | Government |
The European Commission | Government |
- Beurs
- Insiders
- John W. Martin
- Ervaring